Tarsus Pharmaceuticals
TARS
TARS
75 hedge funds and large institutions have $351M invested in Tarsus Pharmaceuticals in 2022 Q3 according to their latest regulatory filings, with 9 funds opening new positions, 28 increasing their positions, 20 reducing their positions, and 7 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
3% more funds holding
Funds holding: 73 → 75 (+2)
0.97% more ownership
Funds ownership: 75.89% → 76.85% (+0.97%)
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
Holders
75
Holding in Top 10
2
Calls
$1.31M
Puts
$13K
Top Buyers
| 1 | +$4.79M | |
| 2 | +$1.77M | |
| 3 | +$1.65M | |
| 4 |
RCMNY
Rubric Capital Management (New York)
New York
|
+$1.41M |
| 5 |
Geode Capital Management
Boston,
Massachusetts
|
+$1.09M |
Top Sellers
| 1 | -$2.73M | |
| 2 | -$1.09M | |
| 3 | -$924K | |
| 4 |
VC
Vivo Capital
Palo Alto,
California
|
-$859K |
| 5 |
SG Americas Securities
New York
|
-$737K |